GlassScriptPhysician profile
Malini Dolon Sur
NPI 1679731251
$9,400.23
in general payments reported to CMS, 2019-2025
16 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,191 · 2020: $183 · 2021: $1,571 · 2022: $482 · 2023: $572 · 2024: $523 · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518 · Travel and Lodging: $1,151 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Education: $4.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.94 |
| Travel and Lodging | $1,151.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Education | $4.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,518.32 | 2019-2025 | Da Vinci Sp |
| Merck Sharp & Dohme LLC | $1,187.82 | 2019 | |
| Abbvie INC. | $372.44 | 2021-2025 | |
| Angiodynamics, INC. | $314.48 | 2020-2024 | Nanoknife |
| Ethicon US, LLC | $188.70 | 2020-2025 | Echelon; Endopath, Evarrest, Enseal |
| Boston Scientific Corporation | $162.18 | 2023 | |
| Iovance Biotherapeutics, INC. | $154.45 | 2025 | Amtagvi |
| Sirtex Medical INC | $144.28 | 2020-2024 | Sir-Spheres Microspheres |
| Medtronic, INC. | $103.81 | 2025 | Signia, Emprint |
| Baxter Healthcare | $92.95 | 2021-2025 | Floseal, Tisseel |
| Integra Lifesciences Corporation | $50.47 | 2020-2025 | Integra, Surgimend, Omnigraft |
| Siemens Medical Solutions USA, INC. | $32.64 | 2025 | Microthermx Microwave Ablation System |
| Astrazeneca Pharmaceuticals LP | $25.80 | 2025 | |
| Alcresta Therapeutics, INC. | $19.57 | 2025 | Relizorb |
| Curium US LLC | $19.44 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malini Sur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.